The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
POT-GFR-PK is a single dose pharmacokinetic study oral tetrahydrocannabinol (THC) and
cannabidiol (CBD) in healthy adult controls and individuals with chronic kidney disease
including those treated with in-center hemodialysis.